Table of Content - Remicade Market

The Global Remicade Market is estimated to be valued at USD 1,422.0 Mn in 2025 and is expected to reach USD 655.0 Mn by 2032, exhibiting a compound annual growth rate (CAGR) of -10.48% from 2025 to 2032. Despite the prevalence of autoimmune diseases such as rheumatoid arthritis, Crohn's disease, and ulcerative colitis, the Remicade market is on a decline. Although Remicade, a monoclonal antibody targeting tumor necrosis factor-alpha (TNF-α), has been effective in managing these conditions, the market faces several challenges. The high cost of treatment, emergence of biosimilars, and growing competition from alternative therapies have significantly limited the market's growth potential. As a result, the Remicade market is contracting, with growth prospects becoming increasingly limited in the coming years.

Market Dynamics

The global Remicade market is currently experiencing a decline, influenced by several key factors. While autoimmune diseases have historically supported demand for effective treatments, the market is now facing substantial hurdles. The high cost of Remicade treatment has restricted access to the drug, particularly in low- and middle-income regions. Additionally, the rise of biosimilars offering cheaper alternatives is eroding Remicade’s market share. Competition from newer therapies, as well as pricing pressures, are contributing to the market’s decline. As a result, despite ongoing efforts to expand indications and develop new formulations, the increasing competition and pricing challenges are severely limiting any potential for growth in the market.

Key Features of the Study

This report provides in-depth analysis of the global Remicade market, and provides market size (USD Mn) and compound annual growth rate (CAGR%) for the forecast period (2025–2032), considering 2024 as the base year
It elucidates potential revenue opportunities across different segments and explains attractive investment proposition matrices for this market
This study also provides key insights about market drivers, restraints, opportunities, new product launches or approvals, market trends, regional outlook, and competitive strategies adopted by key players
It profiles key players in the global Remicade market based on the following parameters – company highlights, products portfolio, key highlights, financial performance, and strategies
Key companies covered as a part of this study include Johnson & Johnson Services, Inc.
Insights from this report would allow marketers and the management authorities of the companies to make informed decisions regarding their future product launches, type up-gradation, market expansion, and marketing tactics
The global Remicade market report caters to various stakeholders in this industry including investors, suppliers, product manufacturers, distributors, new entrants, and financial analysts
Stakeholders would have ease in decision-making through various strategy matrices used in analyzing the global Remicade market

Market Segmentation

Indication Insights (Revenue, USD Mn, 2020 - 2032)
- Crohn’s Disease
- Ulcerative Colitis
- Rheumatoid Arthritis
- Ankylosing Spondylitis
- Psoriatic Arthritis
- Plaque Psoriasis
Patient Age Group Insights (Revenue, USD Mn, 2020 - 2032)
- Adult
- Pediatric
- Geriatric
Distribution Channel Insights (Revenue, USD Mn, 2020 - 2032)
- Hospital Pharmacies
- Retail Pharmacies
- Online Pharmacies
Regional Insights (Revenue, USD Mn, 2020 - 2032)
- North America
  - U.S.
  - Canada
- Latin America
  - Brazil
  - Argentina
  - Mexico
  - Rest of Latin America
- Europe
  - Germany
  - U.K.
  - Spain
  - France
  - Italy
  - Russia
  - Rest of Europe
- Asia Pacific
  - China
  - India
  - Japan
  - Australia
  - South Korea
  - ASEAN
  - Rest of Asia Pacific
- Middle East
  - GCC Countries
  - Israel
  - Rest of Middle East
- Africa
  - South Africa
  - North Africa
  - Central Africa
Key Players Insights
- Johnson & Johnson Services, Inc.

Table of Contents

Research Objectives and Assumptions
- Research Objectives
- Assumptions
- Abbreviations
Market Purview
- Report Description
  - Market Definition and Scope
- Executive Summary
  - Global Remicade Market, By Indication
  - Global Remicade Market, By Patient Age Group
  - Global Remicade Market, By Distribution Channel
  - Global Remicade Market, By Region
Market Dynamics, Regulations, and Trends Analysis
- Market Dynamics
- Driver
- Restraint
- Opportunity
- Impact Analysis
- Key Developments
- Regulatory Scenario
- Product Launches/Approvals
- PEST Analysis
- PORTER’s Analysis
- Merger and Acquisition Scenario
- Industry Trends
- Reimbursement Scenario
- Epidemiology
- Pricing Analysis
Global Remicade Market, By Indication, 2020-2032, (USD Mn)
- Introduction
  - Market Share Analysis, 2025 and 2032 (%)
  - Y-o-Y Growth Analysis, 2021 - 2032
  - Segment Trends
- Crohn’s Disease
  - Introduction
  - Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Mn)
- Ulcerative Colitis
  - Introduction
  - Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Mn)
- Rheumatoid Arthritis
  - Introduction
  - Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Mn)
- Ankylosing Spondylitis
  - Introduction
  - Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Mn)
- Psoriatic Arthritis
  - Introduction
  - Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Mn)
- Plaque Psoriasis
  - Introduction
  - Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Mn)
Global Remicade Market, By Patient Age Group, 2020-2032, (USD Mn)
- Introduction
  - Market Share Analysis, 2025 and 2032 (%)
  - Y-o-Y Growth Analysis, 2021 - 2032
  - Segment Trends
- Adult
  - Introduction
  - Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Mn)
- Pediatric
  - Introduction
  - Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Mn)
- Geriatric
  - Introduction
  - Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Mn)
Global Remicade Market, By Distribution Channel, 2020-2032, (USD Mn)
- Introduction
  - Market Share Analysis, 2025 and 2032 (%)
  - Y-o-Y Growth Analysis, 2021 - 2032
  - Segment Trends
- Hospital Pharmacies
  - Introduction
  - Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Mn)
- Retail Pharmacies
  - Introduction
  - Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Mn)
- Online Pharmacies
  - Introduction
  - Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Mn)
Global Remicade Market, By Region, 2020 - 2032, Value (USD Mn)
- Introduction
  - Market Share (%) Analysis, 2025, 2028 & 2032, Value (USD Mn)
  - Market Y-o-Y Growth Analysis (%), 2021 - 2032, Value (USD Mn)
  - Regional Trends
- North America
  - Introduction
  - Market Size and Forecast, By Indication, 2020 - 2032, Value (USD Mn)
  - Market Size and Forecast, By Patient Age Group, 2020 - 2032, Value (USD Mn)
  - Market Size and Forecast, By Distribution Channel, 2020 - 2032, Value (USD Mn)
  - Market Size and Forecast, By Country, 2020 - 2032, Value (USD Mn)
    - U.S.
    - Canada
- Latin America
  - Introduction
  - Market Size and Forecast, By Indication, 2020 - 2032, Value (USD Mn)
  - Market Size and Forecast, By Patient Age Group, 2020 - 2032, Value (USD Mn)
  - Market Size and Forecast, By Distribution Channel, 2020 - 2032, Value (USD Mn)
  - Market Size and Forecast, By Country, 2020 - 2032, Value (USD Mn)
    - Brazil
    - Argentina
    - Mexico
    - Rest of Latin America
- Europe
  - Introduction
  - Market Size and Forecast, By Indication, 2020 - 2032, Value (USD Mn)
  - Market Size and Forecast, By Patient Age Group, 2020 - 2032, Value (USD Mn)
  - Market Size and Forecast, By Distribution Channel, 2020 - 2032, Value (USD Mn)
  - Market Size and Forecast, By Country, 2020 - 2032, Value (USD Mn)
    - Germany
    - U.K.
    - Spain
    - France
    - Italy
    - Russia
    - Rest of Europe
- Asia Pacific
  - Introduction
  - Market Size and Forecast, By Indication, 2020 - 2032, Value (USD Mn)
  - Market Size and Forecast, By Patient Age Group, 2020 - 2032, Value (USD Mn)
  - Market Size and Forecast, By Distribution Channel, 2020 - 2032, Value (USD Mn)
  - Market Size and Forecast, By Country, 2020 - 2032, Value (USD Mn)
    - China
    - India
    - Japan
    - Australia
    - South Korea
    - ASEAN
    - Rest of Asia Pacific
- Middle East
  - Introduction
  - Market Size and Forecast, By Indication, 2020 - 2032, Value (USD Mn)
  - Market Size and Forecast, By Patient Age Group, 2020 - 2032, Value (USD Mn)
  - Market Size and Forecast, By Distribution Channel, 2020 - 2032, Value (USD Mn)
  - Market Size and Forecast, By Country, 2020 - 2032, Value (USD Mn)
    - GCC Countries
    - Israel
    - Rest of Middle East
- Africa
  - Introduction
  - Market Size and Forecast, By Indication, 2020 - 2032, Value (USD Mn)
  - Market Size and Forecast, By Patient Age Group, 2020 - 2032, Value (USD Mn)
  - Market Size and Forecast, By Distribution Channel, 2020 - 2032, Value (USD Mn)
  - Market Size and Forecast, By Country/Region, 2020 - 2032, Value (USD Mn)
    - South Africa
    - North Africa
    - Central Africa
Competitive Landscape
- Johnson & Johnson Services, Inc.
  - Company Highlights
  - Product Portfolio
  - Key Developments
  - Financial Performance
  - Strategies
Analyst Recommendations
- Wheel of Fortune
- Analyst View
- Coherent Opportunity Map
References and Research Methodology
- References
- Research Methodology
- About us

*Browse 32 market data tables and 28 figures on ‘Remicade Market' - Global forecast to 2032

Need a Custom Report?

We can customize every report - free of charge - including purchasing stand-alone sections or country-level reports
Customize Now

Credibility and Certifications

860519526

9001:2015

27001:2022

REMICADE MARKET SIZE AND SHARE ANALYSIS - GROWTH TRENDS AND FORECASTS (2025 - 2032)

Need a Custom Report?

EXISTING CLIENTELE